These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 206044)

  • 21. Incidence of hepatitis associated antigen in chronic liver disease in Southern Italy.
    Del Vecchio-Blanco C; Carrella M; Coltorti M
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):138-42. PubMed ID: 4356375
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.
    Dudley FJ; O'Shea MJ; Sherlock S
    Clin Exp Immunol; 1973 Mar; 13(3):367-72. PubMed ID: 4349710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
    Uehara M; Sato N
    Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The existence of alpha 1-fetoprotein apart from hepatoma].
    Andrieu J; Breart G; Rodier B; Robert PE
    Presse Med (1893); 1971; 79(36):1595-6. PubMed ID: 4328551
    [No Abstract]   [Full Text] [Related]  

  • 25. Carcinoma of the pancreas. Detection and monitoring by carcinoembryonic antigen (CEA) and ultrasonography.
    Lokich JJ; Chawla PL; Smith EH
    Am J Gastroenterol; 1974 Dec; 62(6):481-7. PubMed ID: 4447096
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the immunologic sensitizability of tumor patients].
    Hegemann F
    Arch Geschwulstforsch; 1968; 32(4):339-52. PubMed ID: 4308112
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular sensitivity to collagen in liver disease.
    Sawada H; Suou T; Hirayama C
    Clin Exp Immunol; 1985 Feb; 59(2):364-70. PubMed ID: 2983912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carcinoembryonic antigen (CEA) in digestive tract diseases].
    Gorski M; Jabłonska-Kaszewska I; Bielawski W; Gan J; Dabrowska E; Fenc E
    Pol Tyg Lek; 1980 Jul; 35(27):1009-12. PubMed ID: 7422592
    [No Abstract]   [Full Text] [Related]  

  • 29. Simultaneous assays of cancer-associated antigens in various neoplastic disorders.
    Franchimont P; Zangerle PF; Nogarede J; Bury J; Molter F; Reuter A; Hendrick JC; Collette J
    Cancer; 1976 Dec; 38(6):2287-95. PubMed ID: 63315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of liver-specific antigen in adult human serum.
    Smith JB; Iverson GM
    Clin Exp Immunol; 1973 Feb; 13(2):209-12. PubMed ID: 4120851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma].
    Hasler E; Spengler A; Berchtold R; Brunner KW; de Weck A
    Schweiz Med Wochenschr; 1977 Nov; 107(47):1683-91. PubMed ID: 929129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of CEA determination in breast carcinoma].
    Lamerz R; Pape W; von Lieven H; Ehrhart H; Leonhardt A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1208-12. PubMed ID: 611820
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of serum CEA level in various malignant tumors (author's transl)].
    Kinoshita F; Maekawa A; Baba R; Horiuchi K; Nishikawa M; Watanabe M; Okada K; Kamiyama I; Yano S; Hashimoto K; Yatomi K; Ogasawara T; Nakagawa T; Okada R; Nagai M
    Rinsho Hoshasen; 1978 Feb; 23(2):239-49. PubMed ID: 344947
    [No Abstract]   [Full Text] [Related]  

  • 36. [Radioimmunological determination of the carcinoembryonic antigen and alpha-fetoprotein in tumorous and nontumorous diseases].
    Mel'nik LF
    Vrach Delo; 1979 May; (5):82-5. PubMed ID: 88133
    [No Abstract]   [Full Text] [Related]  

  • 37. [Carbohydrate antigen (CA-19-9) in the blood serum of patients with benign and malignant liver diseases].
    Ametov AS; Kasatkin IuN; Mit'kov VV; Gur'eva IV
    Med Radiol (Mosk); 1985 Mar; 30(3):39-41. PubMed ID: 3856723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis Bs antigen in primary liver cancer].
    Kunchev K
    Vutr Boles; 1978; 17(2):24-7. PubMed ID: 207025
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection and characterization of antibody to liver cell membrane in sera from patients with chronic active liver diseases.
    Tsuji T; Araki K; Naito K; Inoue J; Nacashima H
    Acta Med Okayama; 1979 Feb; 33(1):61-6. PubMed ID: 220848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botkin's viral hepatitis and the problem of the Australia antigen].
    Barinskiĭ IF; Shubladze AK
    Sov Med; 1973 May; 36(5):36-42. PubMed ID: 4358526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.